Your Article Summary
See Latest ArticlesPimecrolimus cream (1%) efficacy in perioral dermatitis - results of a randomized, double-blind, vehicle-controlled study in 40 patients
Journal of the European Academy of Dermatology and Venereology, 09/18/07
Oppel, T., et al. - Perioral dermatitis (POD) is a common skin disease and difficult to treat. Pimecrolimus cream (1%) successfully controls atopic eczema.Our aim was to investigate its efficacy in POD...Conclusion: Results suggest that pimecrolimus cream (1%) effectively treats acute-stage POD
Related Articles
Association between exposure to topical tacrolimus or pimecrolimus and cancers
Annals of Pharmacotherapy, 11/16/09
Relevance Score: 45%
Topical Pimecrolimus: A Review of its Use in the Management of Pediatric Atopic Dermatitis
Pediatric Drugs, 11/06/09
Relevance Score: 45%
Feasibility, Safety, and Efficacy of a Novel Polymeric Pimecrolimus-Eluting Stent
JACC - Journal of the American College of Cardiology: Cardiovascular Interventions, 10/27/09
Relevance Score: 42%
Sertaconazole 2% cream vs. miconazole 2% cream for cutaneous mycoses: a double-blind clinical trial
Clinical and Experimental Dermatology, 10/06/09
Relevance Score: 42%
Prevention of striae gravidarum with cocoa butter cream
International Journal of Gynecology & Obstetrics, 10/01/09
Relevance Score: 42%
Today in Dermatology...keeping you current
Receive free subspecialty "5-minute updates" via email
A Comparative Study of Topical 5-Aminolevulinic Acid Incubation Times in Photodynamic Therapy with Intense Pulsed Light for the Treatment of Inflammatory Acne
Dermatologic Surgery, 12/09/09
Diameter of Involved Nerves Predicts Outcomes in Cutaneous Squamous Cell Carcinoma with Perineural Invasion: An Investigator-Blinded Retrospective Cohort Study
Dermatologic Surgery, 12/09/09
Activation of blood coagulation in chronic urticaria: pathophysiological and clinical implications
Internal and Emergency Medicine, 12/09/09